These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8722335)

  • 1. Clinical results of allogeneic peripheral blood stem cell transplantation: Japanese survey 1995.
    Harada M; Kodera Y; Asano S
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S47-50. PubMed ID: 8722335
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic peripheral blood progenitor cell transplantation--the Australian experience.
    Szer J; Bardy P; Grigg A; Durrant S; Hutchins C; Herrmann R; Atkinson K
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S51-3. PubMed ID: 8722336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current status of allogeneic-peripheral blood stem cell transplantation and the possibility for unrelated donor-peripheral blood stem cell transplantation].
    Shinagawa K; Harada M
    Rinsho Ketsueki; 1998 May; 39(5):342-4. PubMed ID: 9637881
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nationwide survey of allogeneic peripheral blood stem cell transplantation in Japan].
    Takenaka K; Harada M
    Rinsho Ketsueki; 1999 Jun; 40(6):451-4. PubMed ID: 10422276
    [No Abstract]   [Full Text] [Related]  

  • 6. Haematopoietic stem cell transplant activity in Switzerland 1997/1998: a report by the STABMT. Swisstransplant Working Group Blood and Marrow Transplantation.
    Schweiz Med Wochenschr; 2000 Jul; 130(27-28):1027-33. PubMed ID: 10953852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-emptive granulocyte transfusions enable allogeneic hematopoietic stem cell transplantation in pediatric patients with chronic infections.
    Sharon RF; Bierings M; Vrielink H; Versluys B; Boelens JJ
    Bone Marrow Transplant; 2006 Feb; 37(3):331-3. PubMed ID: 16314849
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan Blood Cell Transplantation Study Group.
    Harada M; Shinagawa K; Kawano T; Kasai M; Sawada H; Nakao S; Hyodo H; Aotsuka N; Furukawa T; Hirai H; Eto T; Imai Y; Shimazaki C; Matsue K; Ogawa M; Takaku F
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S54-6. PubMed ID: 9712495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
    Tanimoto TE; Yamaguchi T; Tanaka Y; Saito A; Tajima K; Karasuno T; Kasai M; Kishi K; Mori T; Maseki N; Morishima S; Miyakoshi S; Kasai M; Ohno Y; Kim SW; Numata A; Kami M; Takaue Y; Mori S; Harada M
    Br J Haematol; 2004 May; 125(4):480-93. PubMed ID: 15142119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry.
    Gross TG; Filipovich AH; Conley ME; Pracher E; Schmiegelow K; Verdirame JD; Vowels M; Williams LL; Seemayer TA
    Bone Marrow Transplant; 1996 May; 17(5):741-4. PubMed ID: 8733691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute.
    Hou HA; Yao M; Tang JL; Chen YK; Ko BS; Huang SY; Tien HF; Chang HH; Lu MY; Lin TT; Lin KH; Hsiao CH; Lin CW; Chen YC
    Bone Marrow Transplant; 2009 Feb; 43(4):315-21. PubMed ID: 18836488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Wang JZ; Gao ZY; Zhang YC; Jiang Q; Shi HX; Lu DP
    Bone Marrow Transplant; 2006 Aug; 38(4):291-7. PubMed ID: 16883312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group].
    Brunet S; Urbano-Ispizua A; Solano C; Ojeda E; Caballero D; Torrabadella M; de la Rubia J; Pérez-Oteiza J; Moraleda J; Espigado I; de la Serna J; Petit J; Bargay J; Mataix R; Vivancos P; Figuera A; Sierra J; Domingo-Albós A; Hernández F; García Conde J; Rozman C
    Sangre (Barc); 1997 Apr; 42 Suppl 1():42-3. PubMed ID: 9381301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical characteristics of patients with lymphoproliferative disorders after allogeneic hematopoietic stem cell transplant].
    Gu B; Chen GH; Wang Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1046-9. PubMed ID: 23363801
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab with peripheral blood stem cell transplantation in CD20 lymphoproliferative disorders.
    Mazza P; Palazzo G; Amurri B; Pricolo G; Prudenzano A; Stani L
    Haematologica; 2001 Oct; 86(10):1104-5. PubMed ID: 11602420
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nationwide survey of allogeneic peripheral blood stem cell transplantation from related donors in Japan: current trends and issues].
    Harada M; Takenaka K; Nakao S; Aotsuka N; Sawada H; Shinagawa K; Kasai M; Iseki T; Murata M; Okamoto S; Hyodo H; Kodera Y
    Rinsho Ketsueki; 1999 Nov; 40(11):1160-7. PubMed ID: 10624126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.